Related Experiment Video
Updated: Apr 30, 2026

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
Magnesium: potential roles in neurovascular disease
Jason J Chang1, William J Mack2, Jeffrey L Saver3
1Department of Neurology, University of Southern California , Los Angeles, CA , USA.
Magnesium shows promise for neuroprotection in specific procedures like cardiac surgery and for pre-term infants. However, its effectiveness in stroke and hemorrhage remains uncertain due to administration timing.
Area of Science:
- Neuroscience
- Pharmacology
- Critical Care Medicine
Background:
- Magnesium therapy is explored for neuroprotection in various conditions.
- Cerebrovascular diseases may potentially benefit from magnesium's properties.
Purpose of the Study:
- To review current research on magnesium's role in neurovascular diseases.
- To assess magnesium's efficacy and safety as a neuroprotectant.
Main Methods:
- Comprehensive literature search of PubMed database.
- Inclusion of basic science, translational, meta-analysis, and clinical studies.
Main Results:
- Magnesium did not improve outcomes in ischemic stroke.
- Limited data exists for intracerebral hemorrhage; preliminary subarachnoid hemorrhage studies showed no significant difference from placebo.
- Trends suggest benefit in global ischemia post-cardiac arrest.
- Strongest evidence for neuroprotection in pre-term infants and during cardiac bypass/carotid endarterectomy.
- Magnesium demonstrated an excellent safety profile.
Conclusions:
- Magnesium is safe and easy to administer.
- Promising neuroprotective potential in cardiac surgery, carotid endarterectomy, and pre-term infant hypoxia.
- Efficacy in stroke, intracerebral hemorrhage, and subarachnoid hemorrhage is unclear, possibly due to delayed administration.
- Further trials focusing on early administration are needed to clarify magnesium's role.
More Related Videos
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
The Blood-brain Barrier
Secondary Spinal Cord Injury llI: Pathophysiology
Multiple Sclerosis l: Introduction
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

